- Home
- TECX vs CYH Comparison
TECX vs CYH Comparison
Compare TECX & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECX
- CYH
- Stock Information
- Founded
- TECX 2019
- CYH 1985
- Country
- TECX United States
- CYH United States
- Employees
- TECX N/A
- CYH 60000
- Industry
- TECX
- CYH Hospital/Nursing Management
- Sector
- TECX
- CYH Health Care
- Exchange
- TECX Nasdaq
- CYH Nasdaq
- Market Cap
- TECX 387.1M
- CYH 410.5M
- IPO Year
- TECX 2018
- CYH 1991
- Fundamental
- Price
- TECX $16.01
- CYH $2.89
- Analyst Decision
- TECX Buy
- CYH Hold
- Analyst Count
- TECX 6
- CYH 8
- Target Price
- TECX $79.17
- CYH $3.57
- AVG Volume (30 Days)
- TECX 475.2K
- CYH 1.4M
- Earning Date
- TECX 11-06-2025
- CYH 10-22-2025
- Dividend Yield
- TECX N/A
- CYH N/A
- EPS Growth
- TECX N/A
- CYH N/A
- EPS
- TECX N/A
- CYH N/A
- Revenue
- TECX N/A
- CYH $12,647,000,000.00
- Revenue This Year
- TECX N/A
- CYH N/A
- Revenue Next Year
- TECX N/A
- CYH $2.46
- P/E Ratio
- TECX N/A
- CYH N/A
- Revenue Growth
- TECX N/A
- CYH 0.81
- 52 Week Low
- TECX $13.70
- CYH $2.24
- 52 Week High
- TECX $61.07
- CYH $6.29
- Technical
- Relative Strength Index (RSI)
- TECX 34.36
- CYH 51.65
- Support Level
- TECX $15.92
- CYH $2.86
- Resistance Level
- TECX $18.61
- CYH $3.04
- Average True Range (ATR)
- TECX 1.58
- CYH 0.11
- MACD
- TECX -0.46
- CYH 0.02
- Stochastic Oscillator
- TECX 5.59
- CYH 57.14
About TECX Tectonic Therapeutic Inc. Common Stock
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.